Stem Cell Treatment for Dry Eye Disease
Part of Eyes & vision clinical trials.
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have dry eye disease in both eyes with symptoms like dryness, burning, or eye fatigue
- Your eyes must have specific test results showing tear film problems and a dry eye symptom score of 13 or higher
- You must be able to see at least 0.1 on the vision chart with correction in both eyes
- You cannot have had eye infections, eye surgery, or certain eye treatments in the past 30 days or longer
- You cannot be pregnant, nursing, or unwilling to use contraception during the study
- You must have stable control of other health conditions like high blood pressure or diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cell fortified eye drops can improve tear film stability, tear volume, and dry eye symptoms. If you have dry eye disease and haven't had eye surgery or certain other eye conditions, you may be able to join.
This trial tests whether injecting stem cells around the eyes can help people with severe dry eye caused by graft-versus-host disease (GVHD) after a stem cell or bone marrow transplant. It aims to reduce eye pain and improve vision when standard treatments haven't worked.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
This early-phase trial tests whether a new treatment using exosomes (tiny natural particles) given as eye drops or injections can help people with Sjögren's syndrome who have severe dry eyes that haven't responded to usual treatments. The goal is to see if it's safe and to get early hints of whether it relieves eye symptoms.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.